In vivo effect of clarithromycin on multiple cytochrome P450S

Drug Metabolism and Disposition

Volumn 29, Issue 7, 2001, Pages 1023-1028

  Bruce, Mellssaa ^a   Hall, Stephen D ^a   Haehner Daniels, Barbara D ^a   Gorski, J Christopher ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CLARITHROMYCIN; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; DEXTROMETHORPHAN; DEXTRORPHAN; DRUG METABOLITE; PARAXANTHINE; TOLBUTAMIDE;

ADULT; ARTICLE; CATALYSIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG METABOLISM; DRUG URINE LEVEL; ENZYME ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CAFFEINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLARITHROMYCIN; CROSS-OVER STUDIES; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; MALE; THEOPHYLLINE; TOLBUTAMIDE;

EID: 0034961047     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Attenuation of rifampicin-induced theophylline metabolism by diltiazem/rifampicin coadministration in healthy volunteers
2. Clarithromycin-carbamazepine interaction: A case report
3. Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6
4. Identification and characterization of human cytochrome P450 isoforms interacting with pimozide
5. The antipsychotic clozapine is metabolized by the polymorphic human microsomal and recombinant cytochrome P450 2D6
6. Studies on the mechanism of a fatal clarithromycin-pimozide interaction in a patient with Tourette syndrome
7. Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes
8. Pharmacokinetic drug interactions with antimicrobial agents
9. Concomitant digoxin toxicity and warfarin interaction in a patient receiving clarithromycin
10. In vivo effects of interleukin-10 on human cytochrome P450 activity
11. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin
12. Variability in caffeine metabolism
13. Metabolism of theophylline by cDNA-expressed human cytochromes P-450
14. Comparison of the effect of the macrolide antibiotics erythromycin, clarithromycin, and azithromycin on terfenadine steady-state pharmacokinetics and electrocardiographic parameters
15. A fluvoxamine-caffeine interaction study
16. Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N-demethylation
17. Quantification of dextromethorphan and metabolites: A dual phenotypic marker for cytochrome P450 3A4/5 and 2D6 activity
18. Tefenadine metabolism in human liver. In vitro inhibition by macrolide antibiotics and azole antifungals
19. Hepatic metabolism of tolbutamide: Characterization of the form of cytochrome P-450 involved in methyl hydroxylation and relationship to in vivo disposition
20. Dextromethorphan as a safe probe for debrisoquine hydroxylation polymorphism
21. Metabolism of clozapine by cDNA-expressed human cytochrome P450 enzymes
22. Delayed elevation of international normalized ratio with concurrent clarithromycin and warfarin therapy
23. Pharmacokinetic drug interactions of macrolides
24. Metabolism and bioactivation of clozapine by human liver in vitro
25. Griseofulvin and fluvoxamine interactions with the metabolism of theophylline
26. Potential interaction between clarithromycin and warfarin
27. Characterisation of theophylline metabolism by human liver microsomes. Inhibition and immunochemical studies
28. Oxidative metabolism of clarithromycin in the presence of human liver microsomes. Major role role for the cytochrome P4503A (CYP3A) subfamily
29. Polymorphic dextromethorphan metabolism: Co-segregation of oxidative O-demethylation with debrisoquin hydroxylation
30. Possible role of the intestinal P-450 enzyme system in a cyclosporine-clarithromycin interaction
31. Theophylline metabolism in human liver microsomes: Inhibition studies
32. Pharmacokinetic interactions between theophylline and other medication (part I)
33. Pharmacokinetic interactions between theophylline and other medication (part II)
34. Validation of the tolbutamide metabolic ratio for population screening with use of sulfaphenazole to produce model phenotypic poor metabolizers
35. Inhibition of theophylline clearance by troleandomycin